NLRP3 and ischemia: The above scientific investigations have principally examined effects of the genetic elimination of NLRP3 or the latter’s pharmacologic antagonism on the cytoplasmic levels of inflammasome components, the release of downstream inflammatory cytokines and other intracellular proteins, and myocardial contractility and infarct size following ischemia/reperfusion.